Additional Therapeutic Experience

Expertise doesn’t come easy, nor is it a word we take lightly. It comes with a relentless focus, the drive to always be better, and most importantly of all – decades of hands-on experience.

While our therapeutic expertise currently lies in the core areas where we’re most accomplished, our foundational commitment to constantly improve health, extend life, and enhance quality of life has led us to a wealth of clinical experience over the years.

Care that transcends therapeutic area

Our clients break new ground each and every day – opening doors and advancing treatments and cures for all types of patients who are running out of options. It’s this inspiring commitment that fuels our fire to continually push further, grow our collective skill set, successfully execute virtual trials, and ultimately maximize the reach of our helping hand.

Because after all, experience is what drives us.

Our site has been very pleased with Rho’s ability to move us quickly through start up and initiation activities. Rho’s professionalism and responsiveness made it a pleasure to work with them. We initiated two important projects in record time because both study teams were efficient and helpful. We hope that other Sponsors choose Rho as their CRO. Kudos!

Issi Clesson, Director of Clinical Trials, Investigational Drugs & Devices (FDA Focus) Shepherd Center

Join us as we push the boundaries of what’s possible on our endless quest to heal the world. We proudly invite you to experience Rho.

Our Experience

More than 50% of our teams

have been at Rho for 5 years or more

79%

of clients rated Rho superior or very superior compared to other CROs

300+

publications in more than 96 journals

Indications Experience

  • Dental and Craniofacial
    • Behavioral Interventions
    • Cleft Palate
    • Craniofacial Microsomia
    • Craniosynostosis
    • Dental Caries
    • Dental Plaque
    • Dry Mouth
    • Fluoride Exposure
    • Oral Cancer
    • Oral Irritation and Sensitization
    • Oral Wound Healing
    • Periodontal Infections/Gingivitis
    • Periodontal Surgery
    • Oral Mucositis
    • Salivary Gland Dysfunction
    • Sjögren’s Syndrome
    • Taste Sensitivity
    • Teeth Whitening
    • Temporomandibular Disorder
  • Dermatology
    • Acne Vulgaris
    • Alopecia Areata
    • Atopic Dermatitis
    • Pruritus
    • Psoriasis
    • Submental Skin Laxity
    • Wound Healing
  • Hematology
    • Acute Leukemia
    • Atypical Hemolytic-Uremic Syndrome (aHUS)
    • Chronic Myelogenous Leukemia
    • Hemophilia A and B
    • Indolent Non-Hodgkin’s Lymphoma
    • Myelodysplasia
    • Progressive B-cell Chronic Lymphocytic Leukemia
    • Refractory Hematologic Malignancies
    • Sickle Cell Disease
    • Von Willebrand Disease
  • Infectious Disease
    • Anthrax
    • Cholera
    • Hepatitis B
    • Hepatitis C
    • Herpes Zoster
    • HIV / AIDs
    • HPV
    • Influenza
    • MRSA
    • Pneumonia
    • Sepsis
    • Tuberculosis
  • Ophthalmology
    • Age-Related Macular
    • Bacterial Conjunctivitis
    • Behcet’s Disease Uveitis
    • Blepharitis
    • Contact Lens
    • Contact Solution
    • Degeneration
    • Diabetic Macular Edema
    • Dry Eye, Cataracts
    • Glaucoma
    • Intraocular Pressure
    • Ocular Hypertension
    • Ocular Inflammation
    • Pars Plana Vitrectomy
    • Post-Op Pain
    • Presbyopia
  • Pediatrics
    • ADHD
    • Asthma
    • Cystic Fibrosis
    • Dental Caries
    • Otitis Media
    • Peanut Allergy
    • Periodontal Disease
    • Rare and Ultra-rare Diseases
    • Transplant (liver, renal, kidney, heart, lung)
    • Type 1 Diabetes
  • Vaccine
    • Anthrax
    • Cholera
    • Genital HSV-2
    • HIV / SIV
    • Influenza
    • Varicella
    • Yellow Fever

Featured Content

Article

Charting a Path Forward for Risk-Based Quality Management

Read more
White paper

10-Step Clinical Study Protocol Authoring Guide

Read more
webinar

Improve the Inclusion & Exclusion Criteria for Your Next Clinical Trial

Learn more

Success Stories

Achieving Success After Rescuing a Neglected Study

Read more

Delivering Topline Results 36 Hours After Database Lock

Read more

Overcoming Enrollment Obstacles to Exceed Sponsor Expectations

Read more